Another big announcement from $NTLA today! We’ve received a @gatesfoundation grant to develop curative #CRISPR /Cas9 in vivo #sicklecelldisease treatments. 🧬 Read the press release➡️https://t.co/fJOQMhbOvX #conquerSCD https://t.co/vkBt76UrPx